A detailed history of Greenland Capital Management LP transactions in Liquidia Corp stock. As of the latest transaction made, Greenland Capital Management LP holds 45,000 shares of LQDA stock, worth $615,150. This represents 0.08% of its overall portfolio holdings.

Number of Shares
45,000
Previous 20,500 119.51%
Holding current value
$615,150
Previous $241 Million 175.32%
% of portfolio
0.08%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025

SELL
$11.36 - $16.5 $56,800 - $82,500
-5,000 Reduced 10.0%
45,000 $664 Million
Q4 2024

Feb 13, 2025

BUY
$9.82 - $11.8 $491,000 - $590,000
50,000 New
50,000 $588 Million

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $880M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Greenland Capital Management LP Portfolio

Follow Greenland Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenland Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Greenland Capital Management LP with notifications on news.